Banco BTG Pactual’s Biogen BIIB Stock Holding History

Banco BTG Pactual’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-5,861	Closed	-$1.56M	–	169
2022 Q3	$1.56M	Buy	+5,861	New	+$1.24M	0.87%	27

Other funds holding BIIB

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Banco BTG Pactual's BIIB Position: Q4 2022 in Review

Banco BTG Pactual sold out of Biogen (BIIB) in Q4 2022, closing a stake of 5,861 shares — an estimated $1.56M sold.

Banco BTG Pactual first reported a position in BIIB in Q3 2022 and held it in 1 quarter. The position peaked at $1.56M in Q3 2022. 1,031 funds tracked by Wall St. Rank hold BIIB as of Q4 2022.

Banco BTG Pactual reported no remaining Biogen position as of Q4 2022 after selling out during the quarter.
Banco BTG Pactual sold 5,861 Biogen shares in Q4 2022, an estimated $1.56M.
Banco BTG Pactual first reported a position in Biogen in Q3 2022 and held it in 1 quarter.
Banco BTG Pactual's Biogen position peaked at $1.56M in Q3 2022.
1,031 funds tracked by Wall St. Rank held Biogen as of Q4 2022.

Based on Banco BTG Pactual's 13F filing for Q4 2022, filed 8 Feb 2023.